Jingbang Wu

439 total citations
7 papers, 289 citations indexed

About

Jingbang Wu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jingbang Wu has authored 7 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Jingbang Wu's work include MicroRNA in disease regulation (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Circular RNAs in diseases (2 papers). Jingbang Wu is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Circular RNAs in diseases (2 papers). Jingbang Wu collaborates with scholars based in China and Madagascar. Jingbang Wu's co-authors include Shusen Zheng, Jian Wu, Xiaode Feng, Beng Yang, Haiyang Xie, Rongliang Tong, Junru Chen, Zhen Lv, Yanpeng Zhang and Lin Zhou and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and EBioMedicine.

In The Last Decade

Jingbang Wu

7 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingbang Wu China 5 238 178 32 23 23 7 289
Gao‐Ren Wang China 8 195 0.8× 144 0.8× 38 1.2× 21 0.9× 47 2.0× 11 247
Qiang Zhan China 8 271 1.1× 246 1.4× 40 1.3× 31 1.3× 23 1.0× 13 336
Youmao Tao China 11 259 1.1× 194 1.1× 63 2.0× 27 1.2× 15 0.7× 17 325
Su‐Ning Huang China 8 239 1.0× 188 1.1× 23 0.7× 45 2.0× 23 1.0× 23 304
Junju He China 4 252 1.1× 202 1.1× 63 2.0× 22 1.0× 25 1.1× 8 321
Ning He China 9 230 1.0× 178 1.0× 30 0.9× 28 1.2× 20 0.9× 11 310
Xiao-Peng Tian China 4 199 0.8× 169 0.9× 21 0.7× 26 1.1× 7 0.3× 5 244

Countries citing papers authored by Jingbang Wu

Since Specialization
Citations

This map shows the geographic impact of Jingbang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbang Wu more than expected).

Fields of papers citing papers by Jingbang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingbang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbang Wu. The network helps show where Jingbang Wu may publish in the future.

Co-authorship network of co-authors of Jingbang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingbang Wu. A scholar is included among the top collaborators of Jingbang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingbang Wu. Jingbang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Chen, Wei, Junnan Ru, Da Man, et al.. (2022). MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 640. 1–11. 1 indexed citations
2.
3.
Zhang, Yanpeng, Jingbang Wu, Yunhao Chen, et al.. (2020). Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy. Technology in Cancer Research & Treatment. 19. 1079211922–1079211922. 4 indexed citations
4.
Wu, Jingbang, Beng Yang, Yanpeng Zhang, et al.. (2019). miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5. International Journal of Biological Sciences. 15(8). 1591–1599. 54 indexed citations
5.
Weng, Xiaoyu, Jingbang Wu, Zhen Lv, et al.. (2019). Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5. EBioMedicine. 44. 225–236. 24 indexed citations
6.
He, Bin, Longfei Dai, Xiaoqian Zhang, et al.. (2018). The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction. International Journal of Biological Sciences. 14(13). 1845–1858. 38 indexed citations
7.
Yang, Beng, Rongliang Tong, Hua Liu, et al.. (2018). H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma. International Journal of Oncology. 52(4). 1235–1245. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gao‐Ren Wang Breakdown of academic impact, for papers by Qiang Zhan Breakdown of academic impact, for papers by Youmao Tao Breakdown of academic impact, for papers by Su‐Ning Huang Breakdown of academic impact, for papers by Junju He Breakdown of academic impact, for papers by Ning He Breakdown of academic impact, for papers by Xiao-Peng Tian
Rankless by CCL
2026